Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, today announced an additional $6M in Series B funding, bringing its total Series B raise to $32M. The follow-on round includes new backing from a San Francisco-based investor and marquee angel investors, along with continued support from Alumni Ventures and Joyance Partners.

This latest investment follows Epicore's initial $26M Series B raise led by the Steele Foundation for Hope, and positions the company to accelerate its global expansion and scale next-generation sweat-sensing technologies.

Epicore Biosystems is a digital health company spun out of Northwestern University's Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory. Epicore has developed advanced sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 1000 companies, the Department of Defense, and the National Institute of Health.